Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Watertown, Massachusetts
- Most recent report
- 8-K, filed Sep 28, 2026
- Incorporated
- Delaware
- Filings on record
- 189 filings
- On EDGAR
- CIK 1736730
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 8
News 8 of 25
Prospectuses and Registrations 8 of 15
- 424B3 Prospectus supplement for an offering Aug 12, 2026
- S-3 Shelf registration statement Aug 6, 2026
- S-8 Registration statement for an employee plan Mar 5, 2026
- 424B5 Prospectus supplement for an offering Dec 18, 2025
- FWP Free writing prospectus Dec 18, 2025
- 424B5 Prospectus supplement for an offering Dec 1, 2025
- 424B3 Prospectus supplement for an offering Nov 25, 2025
- S-3 Shelf registration statement Nov 10, 2025
Proxies 4
Ownership 8 of 113
- 4 Insider reported a trade Sep 2, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Aug 31, 2026
- 4 Insider reported a trade Aug 31, 2026
- 4 Insider reported a trade Aug 26, 2026
- 4 Insider reported a trade Aug 21, 2026
- 4 Insider reported a trade Aug 19, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Aug 19, 2026
- 144 Notice of a proposed sale of restricted stock Aug 19, 2026
Other 8 of 24
- EFFECT Notice that a registration became effective Aug 12, 2026
- ARS Annual report sent to shareholders Apr 23, 2026
- ARS Annual report sent to shareholders Apr 30, 2025
- SEC STAFF LETTER Oct 16, 2024
- EFFECT Notice that a registration became effective Oct 10, 2024
- CERT Exchange certified a listing Oct 10, 2024
- 8-A12B Registration of a security for exchange listing Oct 8, 2024
- CORRESP Reply to SEC staff Oct 8, 2024
Everything here comes from Camp4 Therapeutics Corp's own filings on SEC EDGAR. The filing list is rechecked every hour.